Type 1 diabetes immunologist focusing on improving the lives of those living with, or at risk of, Type 1 diabetes
Birmingham, England
Joined March 2021
- Tweets244
- Following460
- Followers323
- Likes1.4K
James Pearson retweeted
We still have 2 places left in our “SMART” study if you have type 1 diabetes and are aged 18-50! See below for a full list of research opportunities…
Do you want to be involved in research? 🔬
By sharing your experience, you can help researchers shape better care, support and understanding for others with type 1 diabetes (T1D). 💙
Explore UK-based research projects looking for people like you.
Tap the link to find out more: bit.ly/4hHlMDT
James Pearson retweeted
Does your family plan on joining us at our Discovery Day in London next Saturday? We'd love to hear from you! 👂
We're looking for families to join us for a quick and informal session, to help us understand the information and support that were most useful to you since diagnosis.
Your opinion will help us shape and improve the support we give to newly diagnosed families. 💙
We're incredibly thankful to The Bukhman Foundation for supporting our Community Engagement work!
Tap the link and sign up today: bit.ly/3UUYNiB 🔗
#DiscoveryDay #GBDoc #BreakthroughT1D
James Pearson retweeted
We are recruiting three volunteers for the Scientific Advisory Council (SAC)🚨
The purpose of the SAC is to provide insightful, independent advice and critical opinions to Breakthrough T1D by guiding our research decisions, policies and position statements.
We are looking for:
- One expert by experience (18-22 y/o)
- One healthcare professional (dietitian)
- One clinical researcher
Find out more about these roles: bit.ly/4cB3xQk 🔗
James Pearson retweeted
Could the time an immunotherapy treatment is given make it more effective for people with type 1 diabetes?
That's the question Dr James Pearson and his team are exploring. Their research is investigating whether delivering treatment when protective immune cells (Tregs) are most 'awake' could improve its ability to slow or prevent the immune system from attacking insulin-producing cells.
It's an innovative approach that could help unlock more effective immunotherapies for type 1 diabetes.
Read more about the project here: bit.ly/49w2flG
@DiabetesUK
#Type1Diabetes #GBDoc #Type1DiabetesGrandChallenge
James Pearson retweeted
BCHC Community Connexions. We remain deeply appreciative of the £2,000 contribution received, from The ELSA study @elsadiabetes who had taken on fundraising challenges, which will support @BCHC_CommCX in organising approximately 2–3 further Community Clinics.
James Pearson retweeted
Meet the team behind the ELSA study: Consultant receives national recognition for leading pioneering T1D research @uhbtrust @unibirmingham
@parthnarendran @RenukaDias @JAPearsonLab
uhb.nhs.uk/news-and-events/n…
James Pearson retweeted
the ELSA study team Celebrated RCP Excellence in Patient Care Awards, these awards celebrate the outstanding contributions of RCP members and fellows worldwide, who are driving improvements in patient care through education, clinical practice, research and policy. @unibirmingham
James Pearson retweeted
Still 6 weeks left to join our “SMART” study if you have type 1 diabetes and are aged 18-50! See below for a full list of research opportunities…
Do you want to be involved in research? 🔬
By sharing your experience, you can help researchers shape better care, support and understanding for others with type 1 diabetes (T1D). 💙
Explore UK-based research projects looking for people like you.
Find out more via the link: bit.ly/4hHlMDT
#Type1Diabetes #GBDoc #Research
James Pearson retweeted
Understanding T1D Burnout: National Survey: Before you decide whether or not to take part, it is important for you to understand why the research is being done and what it will involve 👇 click on link app.onlinesurveys.jisc.ac.uk…
@JAPearsonLab @T1DRAdiabetes @parthnarendran
James Pearson retweeted
A day where we celebrate the work of the ELSA study researchers making a difference to people's lives, not just in Birmingham but the UK. @unibirmingham @parthnarendran @RenukaDias @T1DRAdiabetes @BristolUni @BT1DUK @DiabetesUK @JAPearsonLab @AlexRichter3
James Pearson retweeted
Research Appreciation Day: Medical science has proven time and again that when the resources are provided, great progress in the treatment, cure, and prevention of disease can occur. @BirminghamBRC @unibirmingham @parthnarendran @BT1DUK @DiabetesUK @RenukaDias @JAPearsonLab 👩🔬🔬
James Pearson retweeted
Research Appreciation Day 5th July: Behind every medical breakthrough is a team of dedicated health researchers. Thank you for your tireless fight to improve lives and bring hope to patients worldwide. @T1DRAdiabetes @parthnarendran @unibirmingham @NIHRresearch 👩🔬🩸🔬💊
James Pearson retweeted
@T1DRAdiabetes (ages 8-70) & @elsadiabetes (ages 2-17) are the only studies screening for #T1D risk autoantibodies in the UK. With the recent approval of Teplizumab, this is more important than ever.
Sign up today to find out your eligibility for clinical trials/Tzield treatment
James Pearson retweeted
“Yesterday's landmark approval of teplizumab marks the start of a new age of type 1 diabetes treatment. “For the first time in 100 years, we are moving beyond insulin, with a medicine that targets the root cause of the condition.”
Do you have any questions for the team
James Pearson retweeted
Today, history has been made: NICE has approved teplizumab for use on the NHS in England and Wales.
Teplizumab is the first ever immunotherapy that can delay the onset of type 1 diabetes symptoms for people in the early stages of the condition.
For the first time, we’re not just managing type 1 - we’re changing its course.
This milestone means many things. But above all, it means time.
More time to simply be a child. A reduction in emergency diagnoses and serious complications like diabetic ketoacidosis. A softer landing for individuals and families suddenly facing management of a life-long condition, and with it, renewed hope for the future.
And this achievement belongs to you, our community. Breakthrough T1D funded early-stage research and the clinical trials that made teplizumab a reality. This breakthrough was made possible by your belief and support.
Together, we are changing what’s possible. 💙
Read the full story here: bit.ly/4oJQzoo
#GBDoc #Type1Diabetes #Teplizumab
ALT Text graphic announcing teplizumab approval for NHS use in England and Wales by NICE, described as a historic moment, on a soft gradient background.
ALT Informational graphic explaining teplizumab as a first-of-its-kind immunotherapy that can delay the need to take insulin by about three years.
ALT Eligibility graphic stating teplizumab is approved for people over eight with stage 2 type 1 diabetes, on a light purple background.
ALT Text graphic stating Breakthrough T1D UK funded early research and trials leading to teplizumab, highlighting progress in type 1 diabetes treatment and commitment to finding a cure, with logo on a gradient background.
James Pearson retweeted
A hugely exciting day - Teplizumab has been approved for use in early stage Type 1 diabetes aimed at delaying progression to insulin start. A step change in how we manage Type 1 diabetes and first new drug in over 100 years. Moving us towards insulin free Type 1 Diabetes 1/2
James Pearson retweeted
We're tipping into a new era for type 1 diabetes.
For the first time, a treatment to slow down the development of type 1 in its early stages will be available on the NHS.
Today's decision from NICE means NHS England has 90 days to put services in place to deliver teplizumab.
James Pearson retweeted
Can you help: about 75% of current T1DRA participants are women, researchers are actively urging more men across the UK to step forward to be screened for T1D Sign up:
t1dra.bristol.ac.uk/ready-to… @triggersbroom17 @diabetes_chat @T1DRAdiabetes are you male 18-70yrs T1DRA needs you
